이 에피소드에 관해
Deborah Mash, CEO of DemeRx, is a true pioneer in the psychedelic field, having dedicated over 30 years to the research, development, and legalization of ibogaine for addiction. This fascinating conversation delves into the science, experience, and safety behind ibogaine's "neurochemical reset" as well as navigating the US drug regulatory system and intellectual property. Hear about the exciting clinical trials underway through DemeRx's partnership with ATAI Life Sciences and Deborah's predictions for ibogaine's legal future.
영어
미국
전사 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
이 팟캐스트의 다른 에피소드
Step into the powerful world of Laura Dawn, creator of the Psychedelic Leadership podcast and Your Message is Your Medicine - a training program for women entrepreneurs in the psychedelic space. Laura weaves science with wisdom teachings to inspire creativity through what she calls "applied imagina…
I am so PSYCHED about @amanda_siebert's new book and our conversation on the PSYCHED podcast (gotta love the synergy!) Tune in to learn all about 7 cutting-edge psychedelics that are changing the world from a fabulous journalist who knows how to explain these medicines in a way that will even ge…
DaeEss 1Dreah, formerly known as Dr. Andrea Pennington, is an American integrative physician, Psychedelic Assisted Therapy Facilitator, bestselling author, executive at Beckley Retreats, international speaker with over 4 million views of her TED talks, host of the Conscious Evolution Podcast, and S…
For psychedelic medicines to reach the people who need them most, they must be covered by health insurance. And Sherry Rais, CEO and co-founder Enthea, is on a mission to make that a reality. With new companies joining the Enthea network each week who realize the incredible benefits to their busine…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Kaia Roman에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.
